Researchers
Discover all researchers in life sciences
Loading researchers...
Maher Kurdi
Researcher at Research Department
Artificial Intelligence
Genetics
Glioma Diagnosis And Treatment
Inflammatory Myopathies And Dermatomyositis
Meningioma And Schwannoma Management
330
Citations
10
H-index
0
Patents
64
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Maher Kurdi's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Investigating the Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma
This study examined the relationship between IDH1 mutation and MGMT promoter methylation and their impact on recurrence-free interval in glioblastoma patients treated with radiotherapy and chemotherapy.
Pathology & Oncology Research (2021)
Analyzing the Role of CD204-Expressed Tumor-Associated Macrophages (TAMs) in Glioblastoma
This research explored the association between CD204-expressing TAMs, tumor-infiltrating lymphocytes, and microglial activation in the glioblastoma microenvironment, identifying potential immune checkpoint receptor targets.
Discover Oncology (2021)
Histomolecular Diagnosis of Central Nervous System Gliomas Based on the 2021 WHO Classification
This work presents a simplified approach for the histomolecular diagnosis of central nervous system gliomas, aligning with the 2021 World Health Organization classification.
World Journal of Clinical Oncology (2022)
Examining the Extracranial Metastasis of Brain Glioblastoma
This study revisits the pathogenesis of extracranial metastasis of brain glioblastoma, providing insights into the mechanisms of tumor spread outside the central nervous system.
Cancer Reports (2023)
Exploring the Synergistic Effect of IDH Mutation and NDRG-2 Dysregulation in Grade 4 Astrocytomas
This research investigates the interplay between IDH mutation and NDRG-2 dysregulation in the progression of WHO-grade 4 astrocytomas, contributing to the understanding of tumor development.
Pathology - Research and Practice (2023)
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment
This study investigates the crosstalk between cancer metabolism and tumour associated macrophage recruitment in the tumour microenvironment of WHO-Grade 4 Astrocytoma.
Biologics (2023)
Research Highlights
Dr. Maher Kurdi is a leading researcher in neuro-oncology, focusing on the molecular mechanisms of brain tumors and the development of novel diagnostic and therapeutic approaches. His work has significantly contributed to understanding the role of immune microenvironment in glioblastoma and other neurological disorders.
Research Areas
Artificial IntelligenceGeneticsGlioma Diagnosis And TreatmentInflammatory Myopathies And DermatomyositisMeningioma And Schwannoma Management
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...